123 related articles for article (PubMed ID: 14978904)
1. [Long-term application of percutaneous cardiopulmonary support system without systemic heparinization].
Miura M; Fukuju T
Kyobu Geka; 2004 Feb; 57(2):115-8. PubMed ID: 14978904
[TBL] [Abstract][Full Text] [Related]
2. [Application of heparin-coated percutaneous cardiopulmonary support system to elective cardiac and aortic operations].
Watanabe SI; Hayashi K; Yamanishi H; Tomioka H; Minami M; Shindo N; Miyamoto K
Kyobu Geka; 1997 May; 50(5):362-7. PubMed ID: 9136530
[TBL] [Abstract][Full Text] [Related]
3. Heparin coated percutaneous cardiopulmonary support for the treatment of circulatory collapse after cardiac surgery.
Kawahito K; Ino T; Adachi H; Ide H; Mizuhara A; Yamaguci A
ASAIO J; 1994; 40(4):972-6. PubMed ID: 7858334
[TBL] [Abstract][Full Text] [Related]
4. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of percutaneous cardiopulmonary support.
Sasako Y; Nakatani T; Nonogi H; Miyazaki S; Kito Y; Takano H; Kawashima Y
Artif Organs; 1996 Jun; 20(6):733-6. PubMed ID: 8817989
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous cardiopulmonary support with heparin-coated circuits in postcardiotomy cardiogenic shock. Efficacy and comparison with left heart bypass.
Hayashi Y; Ohtake S; Sawa Y; Nishimura M; Ichikawa H; Satoh H; Yamaguchi T; Suhara H; Sakaguchi T; Matsuda H
Jpn J Thorac Cardiovasc Surg; 2000 May; 48(5):274-9. PubMed ID: 10860279
[TBL] [Abstract][Full Text] [Related]
7. [Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
Kusaba T; Nakahara Y; Matsumuro A; Nakamura T; Sawada S
J Cardiol; 2004 Apr; 43(4):185-91. PubMed ID: 15125383
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
9. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support.
Sung K; Lee YT; Park PW; Park KH; Jun TG; Yang JH; Ha YK
Ann Thorac Surg; 2006 Aug; 82(2):651-6. PubMed ID: 16863780
[TBL] [Abstract][Full Text] [Related]
10. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
11. Heparin rebound phenomenon--much ado about nothing?
Martin P; Horkay F; Gupta NK; Gebitekin C; Walker DR
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):187-91. PubMed ID: 1606290
[TBL] [Abstract][Full Text] [Related]
12. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
13. [Relatively long time use of percutaneous cardiopulmonary support after unsuccessful weaning from intra-operative extracorporeal circulation--clinical considerations from an experience of 5 patients].
Yamanishi H; Watanabe S; Hayashi K
Nihon Kyobu Geka Gakkai Zasshi; 1995 Oct; 43(10):1783-7. PubMed ID: 7594840
[TBL] [Abstract][Full Text] [Related]
14. Flow rate dependent ex vivo deheparinization with immobilized cationic ligand.
Tevaearai HT; Mueller XM; Marty B; Horisberger J; Schapira M; von Segesser LK
ASAIO J; 1997; 43(5):M487-9. PubMed ID: 9360090
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of percutaneous cardiopulmonary support in severe heart failure: early results and analysis of complications.
Sakamoto S; Matsubara J; Matsubara T; Nagayoshi Y; Shono S; Nishizawa H; Kanno M; Takeuchi K; Nonaka T; Kyosawa J
Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):105-10. PubMed ID: 12732087
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients].
Jiang L; Yu JF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW
J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706
[TBL] [Abstract][Full Text] [Related]
18. Postoperative bleeding in cardiovascular surgery. Does heparin rebound really exist?
Gundry SR; Drongowski RA; Klein MD; Coran AG
Am Surg; 1989 Mar; 55(3):162-5. PubMed ID: 2919841
[TBL] [Abstract][Full Text] [Related]
19. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
20. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
